105
Participants
Start Date
June 7, 2024
Primary Completion Date
July 31, 2026
Study Completion Date
January 31, 2027
Mycophenolate Mofetil
MMF dosed 600mg/m2 body surface area per dose about every 12 hours
Mycophenolate Mofetil
MMF dosed twice daily to achieve an area under the concentration-time curve (AUC 0-12h) of MPA \>=60-70 mg\*h/L
RECRUITING
Hospital for Special Surgery, New York
RECRUITING
Children's Hospital at Montefiore, New York
RECRUITING
University of North Carolina at Chapel Hill, Chapel Hill
RECRUITING
Medical University of South Carolina, Charleston
RECRUITING
Emory Children's Center, Atlanta
RECRUITING
Nationwide Children's Hospital, Columbus
RECRUITING
University Hospitals Cleveland Medical Center, Cleveland
RECRUITING
Akron Children's Hospital, Akron
RECRUITING
Cincinnati Children's Hospital Medical Center, Cincinnati
RECRUITING
Children's Wisconsin/Medical College of Wisconsin, Milwaukee
RECRUITING
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
RECRUITING
University of Chicago Medicine- Comer Children's, Chicago
RECRUITING
Washington University in St. Louis School of Medicine, St Louis
RECRUITING
Baylor College of Medicine Pediatric Immunology Allergy Rheumatology, Houston
RECRUITING
Children's Hospital Colorado, Aurora
RECRUITING
University of Utah, Salt Lake City
RECRUITING
University of California, San Francisco, San Francisco
RECRUITING
Seattle Children's Hospital/University of Washington, Seattle
RECRUITING
Hackensack University Medical Center, Hackensack
Collaborators (1)
Genentech, Inc.
INDUSTRY
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
NIH
Children's Hospital Medical Center, Cincinnati
OTHER